Company Filing History:
Years Active: 2009-2017
Title: **J Carrie Schneider: Innovator in Sphingomonas Research**
Introduction
J Carrie Schneider is a notable inventor based in San Diego, California. With a remarkable portfolio of nine patents, Schneider has significantly contributed to the field of biotechnology, particularly in the development of mutant bacterial strains and their applications.
Latest Patents
One of Schneider’s latest inventions involves mutant bacterial strains of the genus Sphingomonas that are deficient in the production of polyhydroxybutyrate (PHB). This innovative work provides a process for the clarification of sphingans, focusing on creating a solution from PHB-deficient Sphingans. The process involves heating an aqueous Sphingan solution at temperatures ranging from 30°C to 70°C, followed by treatment with a clarification agent and enzymes. Additionally, the invention offers potential applications in food or industrial products, particularly featuring clarified, PHB-deficient high-acyl gellan.
Career Highlights
Throughout his career, Schneider has been affiliated with prominent companies, such as CP Kelco U.S., Inc. and Pfenex Inc. These positions have allowed him to apply his innovative ideas in practical settings, further advancing research in microbial biotechnology.
Collaborations
J Carrie Schneider has worked alongside accomplished colleagues, including Stan Bower and Ellen Burke. Their collaborative efforts have fostered advancements in the research and development of Sphingomonas strains, significantly impacting various industrial processes.
Conclusion
In summary, J Carrie Schneider stands out as a pioneering inventor in the realm of biotechnology. His advancements in mutant bacterial strains and processes for sphingan clarification demonstrate the potential to revolutionize food and industrial products. Schneider's career reflects a commitment to innovation and collaboration, positioning him as a vital contributor to the field.